MAT
43
-7
CHRW
59
-3
TRV
42
-4
TGNA
35
-5
ITW
37
-5
VMC
53
-4
LB
37
-7
PFE
46
-5
COST
50
-4
LOW
42
-4
SYK
40
-2
HOG
33
-3
PBI
46
-4
FAST
53
-6
NWS
50
-4
AEE
66
-5
WFC
63
-3
GOOG
69
-2
EXR
51
-4
MTCH
40
-4
MAT
43
-7
CHRW
59
-3
TRV
42
-4
TGNA
35
-5
ITW
37
-5
VMC
53
-4
LB
37
-7
PFE
46
-5
COST
50
-4
LOW
42
-4
SYK
40
-2
HOG
33
-3
PBI
46
-4
FAST
53
-6
NWS
50
-4
AEE
66
-5
WFC
63
-3
GOOG
69
-2
EXR
51
-4
MTCH
40
-4
Financhill
Back

Apollo Asset Management, Inc. Vs. Akero Therapeutics Industry Stock Comparison

Sell
37

APO
Apollo Asset Management, Inc.

Last Price:
$132.10
Seasonality Move:
2.14%
Buy
64

AKRO
Akero Therapeutics

Last Price:
$55.60
Seasonality Move:
13.24%
Sell
37
Apollo Asset Management, Inc. (APO) is a Sell

Is Apollo Asset Management, Inc. a Buy, Sell or Hold?

  • The current Apollo Asset Management, Inc. [APO] share price is $132.11. The Score for APO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • APO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $55.62. The Score for AKRO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APO Stock Price Chart

What is Apollo Asset Management, Inc.'s stock price today?

  • The Apollo Asset Management, Inc. share price today is $132.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APO is experiencing selling pressure, which indicates risk of future bearish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $55.62
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

APO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 46.32 Sell
Chaikin Money Flow: -2808914 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (130.19 - 140.81) Sell
Bollinger Bands (100): (126.77 - 156.75) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.22 Buy
Relative Strength Index (14 RSI): 69.42 Buy
Chaikin Money Flow: 1967952 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.81 - 53.51) Buy
Bollinger Bands (100): (37.5 - 51.86) Buy

APO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 133.93 Sell
20-day SMA: 133.91 Sell
50-day SMA: 131.44 Buy
200-day SMA: 144.61 Sell
8-day EMA: 134.35 Sell
20-day EMA: 134.05 Sell
50-day EMA: 135.31 Sell
200-day EMA: 137.87 Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.07 Buy
20-day SMA: 49.61 Buy
50-day SMA: 43.75 Buy
200-day SMA: 36.79 Buy
8-day EMA: 53.49 Buy
20-day EMA: 50.33 Buy
50-day EMA: 46.33 Buy
200-day EMA: 38.56 Buy

Apollo Asset Management, Inc. Earnings Growth & APO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.32 per share, an increase this year of $0.67 per share, and an increase next year of $1.61 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

Apollo Asset Management, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):